Beyond Representation Learning: A Systematic Study of Joint-Embedding Predictive Generation for 3D Brain MRI
Organizations: University of Toronto · University of Waterloo · University of Alberta · University of Sussex
Abstract
Joint-embedding predictive architectures (JEPAs) have primarily been developed for self-supervised representation learning. Denoising JEPA (D-JEPA) recently demonstrated strong generative capabilities on natural images, yet the applicability to 3D medical imaging remains unexplored. Building on the D-JEPA framework, we present Med-D-JEPA, a systematic adaptation and evaluation of joint-embedding predictive generation for 3D brain MRI. Med-D-JEPA operates on continuous latent tokens produced by a 3D KL-regularized adversarial variational autoencoder, and combines masked context prediction, representation-level alignment, per-token diffusion, and iterative next-set-of-token sampling. We evaluate unconditional and class-conditional generation quality on BraTS2019 and OASIS-1 datasets; downstream classification utility; and preliminary whole-tumor segmentation on BraTS2020. Across different generation settings, Med-D-JEPA achieves superior or competitive performance compared to several strong baselines on fidelity and diversity metrics. Compared to training with real samples, Med-D-JEPA-based synthetic pretraining improves classification AUC from 0.63 to 0.85 on BraTS2019 and from 0.78 to 0.87 on OASIS-1. In the segmentation study, pretraining on Med-D-JEPA samples improves Dice from 0.74 to 0.80 and reduces HD95 from 13.40 to 9.56 mm. These findings establish joint-embedding predictive generation as a promising direction for 3D medical image synthesis and encourage further research in this direction.
Figures & tables
| Type | Method | MMD | MS-SSIM (%) | FID-Avg. | Prec. | Rec. |
|---|---|---|---|---|---|---|
| (a) Unconditional | ||||||
| Mixed | 3D-HA-GAN [ 47 ] | 2.08 | 95.7 | 90.0 | 0.23 0.03 | 0.20 0.05 |
| Medical Diffusion [ 29 ] | 1.79 | 90.9 | 33.4 | 0.45 0.02 | 0.42 0.04 | |
| 3D-MedDiffusion [ 51 ] | 1.76 | 89.3 | 33.9 | 0.45 0.04 | 0.50 0.02 | |
| 3D-VQGAN [ 58 ] | 1.78 | 88.1 | 32.9 | 0.47 0.06 | 0.53 0.09 | |
| Med-D-JEPA (Ours) | 1.68 | 85.4 | 26.5 | 0.58 0.03 | 0.57 0.07 | |
| Cohort | Method | MMD | MS-SSIM (%) | FID-Avg. | Prec. | Rec. |
|---|---|---|---|---|---|---|
| (a) Unconditional | ||||||
| Mixed | 3D-HA-GAN [ 47 ] | 1.82 | 82.1 | 72.0 | 0.41 0.03 | 0.35 0.07 |
| Medical Diffusion [ 29 ] | 1.58 | 80.2 | 27.0 | 0.65 0.09 | 0.42 0.03 | |
| 3D-MedDiffusion [ 51 ] | 1.60 | 75.2 | 29.8 | 0.61 0.06 | 0.51 0.05 | |
| 3D-VQGAN [ 58 ] | 1.50 | 81.2 | 26.7 | 0.72 0.05 | 0.53 0.04 | |
| Med-D-JEPA (Ours) | 1.46 | 74.4 | 23.6 | 0.71 0.07 | 0.53 0.01 | |
| Method | /class | AUC | F1-Score | Accuracy |
|---|---|---|---|---|
| Method comparison | ||||
| Real only | 0 | |||
| Real + traditional augmentation | 0 | |||
| 3D-HA-GAN [ 47 ] | 300 | |||
| Medical Diffusion [ 29 ] | 300 | |||
| 3D-MedDiffusion [ 51 ] | 300 | 0.79 0.03 | 0.68 0.04 | 0.70 0.04 |
| Method | /class | AUC | F1-Score | Accuracy |
|---|---|---|---|---|
| Method comparison | ||||
| Real only | 0 | 0.78 0.08 | 0.60 0.06 | 0.69 0.03 |
| Real + traditional augmentation | 0 | 0.79 0.04 | 0.68 0.07 | 0.73 0.05 |
| 3D-HA-GAN [ 47 ] | 300 | 0.77 0.06 | 0.68 0.02 | 0.74 0.06 |
| Medical Diffusion [ 29 ] | 300 | 0.80 0.04 | 0.73 0.09 | 0.75 0.03 |
| 3D-MedDiffusion [ 51 ] | 300 | 0.81 0.03 | 0.74 0.04 | 0.73 0.03 |
| Training strategy | Dice | HD95 (mm) | |
|---|---|---|---|
| Real only | 0 | 0.74 0.03 | 13.40 5.61 |
| Med-D-JEPA + Real | 300 | 0.80 0.06 | 9.56 3.97 |
| Dataset | Steps | FID-Avg. | Precision | Recall | Time/Volume |
|---|---|---|---|---|---|
| BraTS2019 | 16 | 26.2 | 0.51 | 0.52 | 5.90 |
| 32 | 29.9 | 0.53 | 0.57 | 11.78 | |
| 64 | 24.6 | 0.57 | 0.58 | 20.60 | |
| 512 | 28.7 | 0.55 | 0.57 | 185.79 | |
| OASIS-1 | 16 | 23.3 | 0.65 | 0.51 | 5.88 |
| 32 | 23.2 | 0.66 | 0.55 | 12.71 |
| Variant | BraTS2019 | OASIS-1 | ||||
|---|---|---|---|---|---|---|
| FID-Avg. | Prec. | Rec. | FID-Avg. | Prec. | Rec. | |
| w/o | 28.1 | 0.54 | 0.52 | 25.2 | 0.65 | 0.50 |
| Med-D-JEPA | 26.5 | 0.58 | 0.57 | 23.6 | 0.71 | 0.53 |
Appendix figures & tables9 assets
Supplementary material from the paper’s appendix.
Appendix
| Dataset | PSNR | 3D SSIM | |
|---|---|---|---|
| BraTS2020 | 74 | 30.63 0.89 | 0.91 0.03 |
| OASIS-1 | 60 | 30.70 0.99 | 0.92 0.05 |
| BraTS2019 | 50 | 33.27 0.10 | 0.95 0.04 |
| Tumor type | Method | MMD ( ) | MS-SSIM (%) | FID-A | FID-C | FID-S | Precision | Recall |
|---|---|---|---|---|---|---|---|---|
| (a) Unconditional generation | ||||||||
| Mixed | 3D-HA-GAN [ 47 ] | 2.08 | 95.7 | 92.6 | 87.8 | 89.5 | 0.23 0.03 | 0.20 0.05 |
| Medical Diffusion [ 29 ] | 1.79 | 90.9 | 33.2 | 31.4 | 35.6 | 0.45 0.02 | 0.42 0.04 | |
| 3D-MedDiffusion [ 51 ] | 1.76 | 89.3 | 30.1 | 34.8 | 36.8 | 0.45 0.04 | 0.50 0.02 | |
| 3D-VQGAN [ 58 ] | 1.78 | 88.1 | 28.5 | 32.3 | 37.9 | 0.47 0.06 | 0.53 0.09 | |
| Med-D-JEPA (Ours) | 1.68 | 85.4 | 24.8 | 25.7 | 28.9 | 0.58 0.03 | 0.57 0.07 | |
| Cohort type | Method | MMD ( ) | MS-SSIM (%) | FID-A | FID-C | FID-S | Precision | Recall |
|---|---|---|---|---|---|---|---|---|
| (a) Unconditional generation | ||||||||
| Mixed | 3D-HA-GAN [ 47 ] | 1.82 | 82.1 | 69.7 | 72.4 | 73.8 | 0.41 0.03 | 0.35 0.07 |
| Medical Diffusion [ 29 ] | 1.58 | 80.2 | 26.3 | 27.8 | 26.9 | 0.65 0.09 | 0.42 0.03 | |
| 3D-MedDiffusion [ 51 ] | 1.60 | 75.2 | 31.7 | 30.4 | 27.3 | 0.61 0.06 | 0.51 0.05 | |
| 3D-VQGAN [ 58 ] | 1.50 | 81.2 | 27.8 | 25.9 | 26.5 | 0.72 0.05 | 0.53 0.04 | |
| Med-D-JEPA (Ours) | 1.46 | 74.4 | 23.2 | 22.9 | 24.6 | 0.71 0.07 | 0.53 0.01 | |
| Dataset | Steps | FID-Avg. | Precision | Recall | Time/Volume |
|---|---|---|---|---|---|
| BraTS2019 | 8 | 27.4 | 0.49 | 0.47 | 3.11 |
| 16 | 26.2 | 0.51 | 0.52 | 5.90 | |
| 32 | 29.9 | 0.53 | 0.57 | 11.78 | |
| 64 | 24.6 | 0.57 | 0.58 | 20.60 | |
| 256 | 29.8 | 0.56 | 0.54 | 92.47 | |
| 512 | 28.7 | 0.55 | 0.57 | 185.79 |
| Dataset | CFG | FID-Avg. | Precision | Recall |
|---|---|---|---|---|
| BraTS2019 | 2.0 | 25.3 | 0.57 | 0.55 |
| 2.5 | 25.8 | 0.54 | 0.52 | |
| 3.0 | 25.6 | 0.53 | 0.53 | |
| 3.5 | 25.9 | 0.52 | 0.52 | |
| 4.0 | 25.5 | 0.51 | 0.52 | |
| OASIS-1 | 2.0 | 23.5 | 0.65 | 0.57 |
| Method | Resolution | Time/volume (s) |
|---|---|---|
| 3D-HA-GAN | 1.25 | |
| Medical Diffusion | 8.72 | |
| 3D-VQGAN-cond | 15.82 | |
| Med-D-JEPA | 21.35 | |
| 3D-MedDiffusion | 27.41 | |
| Med-D-JEPA | 42.54 |